These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3197252)

  • 1. ELISA assay for melarsoprol.
    Maes L; Doua F; Hamers R
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):557-60. PubMed ID: 3197252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
    Maes L; Vanderveken M; Hamers R; Doua F; Cattand P
    Ann Soc Belg Med Trop; 1988 Sep; 68(3):219-31. PubMed ID: 3223784
    [No Abstract]   [Full Text] [Related]  

  • 3. An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids.
    Onyango JD; Burri C; Brun R
    Acta Trop; 2000 Jan; 74(1):95-100. PubMed ID: 10643913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy.
    Ericsson O; Schweda EK; Bronner U; Rombo L; Fridén M; Gustafsson LL
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):243-51. PubMed ID: 9106049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS/ESMS.
    Raber G; Raber T; Raml R; Murko M; Magnes C; Francesconi KA
    Talanta; 2013 Nov; 116():876-81. PubMed ID: 24148488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
    Burri C; Brun R
    Trop Med Parasitol; 1992 Dec; 43(4):223-5. PubMed ID: 1293724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
    Burri C; Onyango JD; Auma JE; Burudi EM; Brun R
    Acta Trop; 1994 Oct; 58(1):35-49. PubMed ID: 7863853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of human African trypanosomiasis].
    Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitrypanosomal drug melarsoprol competitively inhibits thiamin uptake in mouse neuroblastoma cells.
    Szyniarowski P; Bettendorff L; Schweingruber ME
    Cell Biol Toxicol; 2006 May; 22(3):183-7. PubMed ID: 16555002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    Robays J; Raguenaud ME; Josenando T; Boelaert M
    Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of an enzyme-linked immunosorbent assay (ELISA) for the determination of the trypanocidal drug homidium in serum of treated cattle.
    Murilla GA; Eisler MC; Peregrine AS; Ndung'u JM; Holmes PH
    J Vet Pharmacol Ther; 1999 Oct; 22(5):301-7. PubMed ID: 10597533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mel W, a new trypanosomicidal agent derived from mel B.
    FRIEDHEIM EA; DE JONGH RT
    Trans R Soc Trop Med Hyg; 1959 May; 53(3):262-9. PubMed ID: 13669031
    [No Abstract]   [Full Text] [Related]  

  • 18. An antigen-capture enzyme-linked immunosorbent assay (ELISA) to detect isometamidium chloride in Oncorhynchus spp.
    Ardelli BF; Woo PT
    Dis Aquat Organ; 2000 Feb; 39(3):231-6. PubMed ID: 10768291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
    Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New contribution on arsobal (R.P. 3854) therapy of trypanosomiasis; its effectiveness in former trypanosomiasis patients, with meningoencephalitis, resistant to trypanocides customarily used].
    CECCALDI J
    Bull Soc Pathol Exot Filiales; 1953; 46(1):95-121. PubMed ID: 13066959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.